Publikācijas » Search Results » 2011

 2018  2017  2016  2015  2014  2013  2012  2011  2010  2009  2008  2007  2006  2005  2004  2003  2002  2001  2000  1999  1998  1997  1996  1995  1994  1993  1992  1991  1990  1989  1988  1987  1986  1985  1984  1983  1982  1981  1980  1979  1978  1977  1976  1975  1974  1973  1972  1971  1970  1969  1968  1967  1966  1965  1964  1962  1961
Rezultātu skaits lapā  
Konferences
71Svalbe B.; Grinberga S.; Veinberg G.; Dambrova M.; Zvejniece L. Comparative pharmacological activity of optical isomers of phenotropil. Abstracts, 43rd Meeting of the European Brain and Behavior Society (EBBS); Sep 9, 2011 - Sep 12: Sevilla, Spain, 2011; 146.      

72Kuka J.; Makrecka M.; Vilskersts R.; Dambrova M. The cardioprotective effect of mildronate is associated with decreased CPT I-dependent fatty acid metabolism in mitochondria. British Cardiovascular Intervention Society BSCR Autumn Meeting, Mitochondria in Cardiovascular Disease: Emerging Concepts and Novel Therapeutic Targets; : London, UK, 2011; 20.      

73Makrecka M.; Kuka J.; Liepinsh E.; Dambrova M. The regulation of mitochondrial energy metabolism by L-carnitine lowering agents in ischemia-reperfusion injury. British Cardiovascular Intervention Society BSCR Autumn Meeting , Mitochondria in Cardiovascular Disease: Emerging Concepts and Novel Therapeutic Targets; : London, UK, 2011; 20.      

74Svalbe B.; Zvejniece L.; Grinberga S.; Liepinsh E.; Dambrova M. Neuroprotective action of mildronate, an inhibitor of L-carnitine biosynthesis, after acute and chronic administration in rats. Abstracts 8th World Congress of Neuroscience, International Brain Research Organization IBRO; July 14-18: D443. Florence, Italy, 2011.      

75Svalbe B.; Zvejniece L.; Liepinsh E.; Dambrova M. Acute and chronic CNS effects of mildronate, an inhibitor of L-carnitine biosynthesis. Abstracts 36th FEBS Congress, Biochemistry for Tomorow,s Medicine; June 25-30: The FEBS Journal, YSF.117. Torino, Italy, 2011; 481.      

76Skapare E.; Konrade I.; Makrecka M.; Liepins E.; Dambrova M. Measurements of the glyoxalase-1 expression and activity in blood samples of diabetic patients. Abstracts 36th FEBS Congress, Biochemistry for Tomorow,s Medicine; June 25-30: The FEBS Journal, P10.45. Torino, Italy, 2011; 188.      

77Svalbe B.; Zvejniece L.; Liepinsh E.; Dambrova M. Acute and chronic CNS effects of mildronate, an inhibitor of L-carnitine biosynthesis. 11th Young Scientist Forum, Biochemistry for Tomorrow,s Medicine; 23-25 June: Torino, Italy, 2011; 117.      

78Segal I.; Zablotskaya A.; Mishnev A.; Maiorov M.; Zablotsky D.; Blums E.; Nikolayeva V. Magnetic Nanostructures of Biological Interest containing Silyl-Model N-(2-Hydroxyethyl)tetrahydroisoquinolines. Program / Abstract Book, Sixteenth International symposium on Silicon Chemistry ISOS XVI ; August 14-18: McMaster University, Hamilton, Ontario, Canada, 2011; 242.      

79Ignatovich L.; Romanovs V.; Starkova O.; Domrachova I.; Shestakova I. New silyl(germyl)hetarylbenzimidazoles: Synthesis and Cytotoxic Activity . Program / Abstract Book , Sixteenth International symposium on Silicon Chemistry ISOS XVI; August 14-18: McMaster University, Hamilton, Ontario, Canada, 2011; 222.      

80Zablotskaya A.; Segal I.; Popelis Yu.; Grinberga S.; Shestakova I. Triorganylsiloxyalkyltetrahydro(iso) and -silaisoquinolines as novel candidates for silyl prodrugs. Program / Abstract Book, Sixteenth International symposium on Silicon Chemistry ISOS XVI; August 14-18: McMaster University, Hamilton, Ontario, Canada, 2011; 120.      

Rezultātu skaits lapā